作为对抗粉样β聚合的调节剂的复合物
Jeasang Yoo1, Jong-Min Suh1, Gunhee Kim1
1Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
Journal of inorganic biochemistry
|June 18, 2025
概括
复合物与环和DMC配体有效地破坏了粉样蛋白-β (Aβ) 聚合,这是阿尔茨海默病的一个关键过程. 这些化合物降低了Aβ毒性,同时在细胞中表现出低的内在毒性.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 材料科学 材料科学 材料科学
背景情况:
- 氨基酸β (Aβ) 聚是阿尔茨海默病的标志,导致认知能力下降.
- 过渡金属复合物提供调节Aβ聚合的潜力,但面临毒性挑战.
- 控制Aβ组合和毒性对于开发阿尔茨海默氏症治疗方法至关重要.
研究的目的:
- 研究-宏环复合物作为Aβ聚合和毒性的调节剂.
- 探索复合物的结构-活性关系与Aβ调制中的Cyclam和DMC配体.
- 评估精选的复合物的有效性和安全性,以减轻Aβ诱导的细胞损伤.
主要方法:
- 用Cyclam和DMC配体合成和表征复合物.
- 关于复合物和Aβ之间的相互作用的机制研究.
- 使用准备好的复合物对Aβ聚合途径的评估.
- 对Aβ和复合物的细胞毒性的评估.
主要成果:
- 合成和表征了复合物,特别是 [Co ((Cyclam) ((NO3)) ] ((NO3), [Co ((Cyclam) ((Cl) 2) Cl, [Co ((DMC) ((H2O) 2))) ((NO3) 2) 和 [Co ((DMC) ((Cl) 2)) Cl,这些复合物都得到了分析.
- 这些复合物与Aβ形成 adducts,将聚合从纤维形成重定向到无形集群和较短的纤维.
- 复合物有效地减轻了活细胞中Aβ诱导的毒性,其内在毒性最小.
结论:
- - 大环复合物作为有效的化学调节剂,用于控制Aβ氨基二代生成.
- 该研究为设计具有量身定制特性的金属复合体提供了一个框架,以对抗Aβ相关的病理.
- 这些发现突出了阿尔茨海默病的有希望的治疗策略,通过准Aβ聚合通路来治疗阿尔茨海默病.
关键词:
吸管形成的形成.粉样蛋白-β粉样蛋白的产生.化学调节器是一种化学调节器.科巴尔特复合物的复合物环 (1,4,8,11-四甲,环四甲) 是一种DMC (1,8-二甲基-1,4,8,11-四甲,环氧四甲) 是一种更多相关视频
09:52Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System
Published on: December 28, 2017
10.8K
04:41Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
23.4K
相关概念视频
Colors and Magnetism
12.4K
Color in Coordination Complexes
When atoms or molecules absorb light at the proper frequency, their electrons are excited to higher-energy orbitals. For many main group atoms and molecules, the absorbed photons are in the ultraviolet range of the electromagnetic spectrum, which cannot be detected by the human eye. For coordination compounds, the energy difference between the d orbitals often allows photons in the visible range to be absorbed and emitted, which is seen as colors by the human...
When atoms or molecules absorb light at the proper frequency, their electrons are excited to higher-energy orbitals. For many main group atoms and molecules, the absorbed photons are in the ultraviolet range of the electromagnetic spectrum, which cannot be detected by the human eye. For coordination compounds, the energy difference between the d orbitals often allows photons in the visible range to be absorbed and emitted, which is seen as colors by the human...
12.4K
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
Amyloid Fibrils
9.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.9K
Valence Bond Theory
9.7K
Coordination compounds and complexes exhibit different colors, geometries, and magnetic behavior, depending on the metal atom/ion and ligands from which they are composed. In an attempt to explain the bonding and structure of coordination complexes, Linus Pauling proposed the valence bond theory, or VBT, using the concepts of hybridization and the overlapping of the atomic orbitals. According to VBT, the central metal atom or ion (Lewis acid) hybridizes to provide empty orbitals of suitable...
9.7K
Complexation Equilibria: The Chelate Effect
683
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
683
Complexometric Titration: Ligands
1.1K
Different monodentate and polydentate ligands are used as complexing agents in complexometric titration reactions. The formation of complexes by mono- and bidentate ligands involves two or more intermediate steps, limiting their use as complexing agents. In comparison, polydentate ligands can form complexes with metal ions in a single-step process, facilitating sharper end points. This means polydentate ligands, such as amino carboxylic acid derivatives, are most commonly employed in...
1.1K
